Maximal standard dose of parenteral iron for hemodialysis patients: An MRI-based decision tree learning analysis

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Rostoker, Guy ^a   Griuncelli, Mireille ^a   Loridon, Christelle ^a   Magna, Théophile ^a   Janklewicz, Philippe ^a   Drahi, Gilles ^a   Dahan, Hervé ^a   Cohen, Yves ^a  

^a Division of Nephrology and Dialysis Hôpital Privé Claude Galien Générale de Santé   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPCIDIN; IRON SACCHARATE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; ANTIANEMIC AGENT; IRON;

ADULT; AGE; AGED; ALGORITHM; ANEMIA; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DECISION TREE; DOSE RESPONSE; FEMALE; HEMODIALYSIS PATIENT; HUMAN; IRON OVERLOAD; LIVER LEVEL; MACHINE LEARNING; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDY; SEX DIFFERENCE; CHEMICALLY INDUCED; CHEMISTRY; DECISION SUPPORT SYSTEM; HEMODIALYSIS; LIVER; MIDDLE AGED; PARENTERAL DRUG ADMINISTRATION; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; CROSS-SECTIONAL STUDIES; DARBEPOETIN ALFA; DECISION SUPPORT TECHNIQUES; DECISION TREES; FEMALE; HEMATINICS; HUMANS; INFUSIONS, PARENTERAL; IRON; IRON OVERLOAD; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; YOUNG ADULT;

EID: 84918772825     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115096     Document Type: Article

References (29)

1. KDOQI National Kidney Foundation (2006) II. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults. Am J Kidney Dis 47 (Suppl. 3): 5 Sl6-S85.
2. Locatelli F, Covic A, Eckardt KU, Wiecek A, Vanholder R and on behalf of the ERA-EDTA ERBP Advisory Board (2009) Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP). Nephrol Dial Transplant 24(2): 348-354.
3. KDIGO Clinical practice Guideline for anemia in chronic kidney disease (2012) Kidney Int Suppl 2: 279-335.
4. Locatelli F, Bárány P, Covic A, De Francisco A, del Vecchio L, et al. on behalf of the ERA-EDTA ERBP Advisory Board (2013) Kidney disease: Improving global outcomes guidelines on anaemia management in chronic kidney disease: an European Renal Best Practice position statement. Nephrol Dial Transplant 28(6): 1346-1359.
5. Besarab A, Coyne DW (2010) Iron supplementation to treat anemia in patients with chronic kidney disease. Nat Rev Nephrol 6(12): 699-710.
6. Rostoker G, Griuncelli M, Loridon C, Couprie R, Benmaadi A, et al. (2012) Hemodialysis-associated hemosiderosis in the era of erythopoesis-stimulating agents: a MRI study. Am J Med 125(10): 991-999.
7. Barton JC, Edwards CQ, Phatak PD, Britton RS, Bacon BR (2010) Handbook of iron overload disorders. Cambridge University Press.
8. Vaziri ND (2012) Epidemic of iron overload in dialysis population caused by intravenous iron products: a plea for moderation. Am J Med 125(10): 951-952.
9. Bailie GR, Larkina M, Goodkin DA, Li Y, Pisoni RL, et al. (2013) Variation in intravenous iron use internationally and over time: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 28(10): 2570-2579.
10. Fishbane S, Mathew A, Vaziri ND (2014) Iron toxicity: relevance for dialysis patients. Nephrol Dial Transplant 29(2): 255-259.
11. KDIGO Controversies Conference on iron management in chronic kidney disease (March 27-30, 2014). San-Francisco, USA.
12. Ali M, Rigolosi R, Fayemi AO, Braun EV, Frascino J, et al. (1982) Failure of serum ferritin levels to predict bone-marrow iron content after intravenous iron-dextran therapy. Lancet 1 (8273): 652-655.
13. Gandon Y, Olivié D, Guyader D, Aubé C, Oberti F, et al. (2004) Non-invasive assessment of hepatic iron stores by MRI. Lancet 363(9406): 357-362.
14. Sheskin DJ (2007) Handbook of parametric and nonparametric statistical procedures. 4th ed. Chapman and Hall/CRC, Taylor and Francis Group.
15. Tobbli JE, Cao G, Oliveri L, Angerosa M (2012) Comparison of oxidative stress and inflammation induced by different intravenous iron sucrose similar preparations in rat model. Inflamm Allergy Drug Targets 11(1): 66-78.
16. Hastie T, Tibshirani R, Friedman J (2001) The elements of statistical learning: Data mining, inference, and prediction. New York: Springer-Verlag.
17. Moisen GG (2008) Classification and regression trees. In: Jorgensen, Sven Erik, Fath, Brian D, Editors. Encyclopedia of Ecology, Volume 1. Oxford, UK: Elsevier p 582-588.
18. Canavese C, Bergamo D, Ciccone G, Longo F, Fop F, et al. (2004) Validation of serum ferritin values by magnetic susceptometry in predicting iron overload in dialysis patients. Kidney Int 65(3): 1091-1098.
19. Ferrari P, Kulkarni H, Dheda S, Betti S, Harrison C, et al. (2011) Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease. Clin J Am Soc Nephrol 6(1): 77-83.
20. Ghoti H, Rachmilewitz EA, Simon-Lopez R, Gaber R, Katzir Z, et al. (2012) Evidence for tissue iron overload in long-term hemodialysis patients and the impact of withdrawing parenteral iron. Eur J Haematol 89(1): 87-93.
21. Feldman HI, Santanna J, Guo W, Furst H, Franklin E, et al. (2002) Iron administration and clinical outcomes in hemodialysis patients. J Am Soc Nephrol 13(3): 734-744.
22. Feldman HI, Joffe M, Robinson B, Knauss J, Cizman B, et al. (2004) Administration of parenteral iron and mortality among hemodialysis patients. J Am Soc Nephrol 15: 1623-1632.
23. Brookhart MA, Freburger JK, Ellis AR, Wang L, Winkelmayer WC, et al. (2013) Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients. J Am Soc Nephrol 24(7): 1151-1158.
24. Bailie GR, Larkina M, Goodkin DA, Li Y, Pisoni RL, et al. (2014) Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality. Kidney Int doi:10.1038/ki.2014.275.
25. Kalantar-Zadeh K, Regidor DL, McAllister CJ, Michael B, Warnock DG (2005) Time-dependent associations between iron and mortality in hemodialysis patients. J Am Soc Nephrol 16(10): 3070-3080.
26. NICE Clinical Guideline 39 (September 2006) Anaemia management in people with chronic kidney disease.
27. Yamamoto H, Tsubakihara Y (2011) Limiting iron supplementation for anemia in dialysis patients: the basis for Japan's conservative guidelines. Semin Dial 24(3): 269-271.
28. Freburger JK, Ng LJ, Bradbury BD, Kshirsagar AV, Brookhart MA (2012) Changing patterns of anemia management in US hemodialysis patients. Am J Med 125(9): 906-914.
29. Pisoni RL, Fuller DS, Bieber BA, Gillespie BW, Robinson BM (2012) The DOPPS Practice Monitor for US dialysis care: trends through August 2011. Am J Kidney Dis 60(1): 160-165.